Immunowake has a total of 28 patents globally. Of these 28 patents, more than 82% patents are active. Canada is where Immunowake has filed the maximum number of patents, followed by Australia, China and United States of America. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Immunowake.
Immunowake is was founded in the year 2019. Immunowake is a biotechnology company that focuses on finding novel treatments for patients who don’t react to current immunotherapies. Using the body’s immune system to recognize and eliminate cancer cells in a manner similar to how pathogens are recognized and eliminated is known as immunotherapy.
Do read about some of the most popular patents of Immunowake which have been covered by us in this article and also you can find Immunowake patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Immunowake patent portfolio.
How many patents does Immunowake have?
Immunowake has a total of 28 patents globally. These patents belong to 5 unique patent families. Out of 28 patents, 23 patents are active.
How Many Patents did Immunowake File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Immunowake Applications Filed | Immunowake Patents Granted |
| 2023 | 6 | – |
| 2022 | 3 | – |
| 2021 | 9 | – |
| 2020 | 3 | – |
| 2018 | 7 | – |
How many Immunowake patents are Alive/Dead?
Worldwide Patents
How Many Patents did Immunowake File in Different Countries?
Countries in which Immunowake Filed Patents
| Country | Patents |
| Canada | 4 |
| Australia | 3 |
| United States Of America | 3 |
| China | 3 |
| Hong Kong (S.A.R.) | 2 |
| South Africa | 2 |
| Europe | 2 |
| Israel | 2 |
| New Zealand | 1 |
| Mexico | 1 |
| Singapore | 1 |
| Brazil | 1 |
Where are Research Centers of Immunowake Patents Located?
Best Immunowake Patents
CN111372950A is the most popular patent in the Immunowake portfolio. It has received 3 citations so far from companies like Dansheng Pharmaceutical Technology (Shanghai), Sansheng Guojian Pharmaceutical (Shanghai), Hangzhou Hansi Biopharmaceutical.
What Percentage of Immunowake US Patent Applications were Granted?
Immunowake (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Immunowake patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Immunowake?
| Law Firm | Total Applications | Success Rate |
| Morrison & Foerster Llp | 2 | 0% |
List of Immunowake Patents
| Immunowake Patents | Title |
| US20230167164A1 | Immunocytokines And Uses Thereof |
| US20220291203A1 | Methods Of Measuring Cell-Mediated Killing By Effectors |
| US20200325208A1 | Vegfr-Antibody Light Chain Fusion Protein |
| EP4263836A1 | Immunocytokines And Uses Thereof |
| EP3694890A4 | Vegfr-Antibody Light Chain Fusion Protein |
| CN116806224A | Immune Cytokines And Their Uses |
| CN114787373A | Method Of Measuring Cell-Mediated Killing By Effector |
| CN111372950A | Vegfr-Antibody Light Chain Fusion Protein |
| CA3211581A1 | Immunomodulatory Molecules And Uses Thereof |
| CA3203239A1 | Immunocytokines And Uses Thereof |
| CA3185107A1 | Vegfr-Antibody Light Chain Fusion Protein |
| AU2022232951A1 | Immunomodulatory Molecules And Uses Thereof |
| AU2021410089A1 | Immunocytokines And Uses Thereof |
| AU2018347521A1 | Vegfr-Antibody Light Chain Fusion Protein |
| HK40077368A | Methods Of Measuring Cell-Mediated Killing By Effectors |
| HK40035996A | Vegfr-Antibody Light Chain Fusion Protein |
| ZA202309430A | Immunomodulatory Molecules And Uses Thereof |
| MX2023007607A | Immunocytocins And Uses Of These |
| IL303967A | Immunocytokines And Uses Thereof |
| SG11202304759WA | Immunocytokines And Uses Thereof |
| ZA202307146A | Immunocytokines And Uses Thereof |
| BR112023012271A2 | Immunocytokin, Methods For Selectively Activating The Activity Of A Cytokine Or Variant Thereof, For Producing An Immunocytokin, For Treat A Disease Or Disorders In A Subject And For Preventing Cancer, Isolated Nucleic Acid, Vector, Isolated Host Cell, Pharmaceutical Composition, And , Cancer Vaccine |
| NZ802028A | Immunocytokines And Uses Thereof |
| WO2022192898A3 | Immunomodulatory Molecules And Uses Thereof |
| WO2022140797A1 | Immunocytokines And Uses Thereof |
| WO2021016598A1 | Methods Of Measuring Cell-Mediated Killing By Effectors |
| CA3078974A1 | Vegfr-Antibody Light Chain Fusion Protein |
| IL273749A | Vegfr-Antibody Light Chain Fusion Protein |
What are Immunowake key innovation segments?
What Technologies are Covered by Immunowake?
The chart below distributes patents filed by Immunowake